WeVote
Log In

Bill

Bill

S 3805

Relates to payment for rapid whole genome sequencing

2025 Regular Session Introduced by Brad Hoylman-Sigal

Bill S 3805 ensures health insurance covers rapid whole genome sequencing, improving access for patients and providing clear reimbursement guidelines for providers.

REPORTED AND COMMITTED TO FINANCE
0
WeVote Research Nonpartisan
Bill Summary · S 3805

Summary of Bill S 3805: Payment for Rapid Whole Genome Sequencing

Bill Overview

  • Bill Number: S 3805
  • Title: Relates to payment for rapid whole genome sequencing
  • Status: Reported and Committed to Finance
  • Introduced On: January 30, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 3805 is to establish guidelines and provisions for the payment of rapid whole genome sequencing (WGS) services. This bill aims to ensure that patients have access to advanced genomic testing, which can significantly enhance the diagnosis and treatment of various medical conditions, particularly genetic disorders.

Key Provisions

  • Payment Structure: The bill outlines a framework for reimbursement for rapid whole genome sequencing, ensuring that healthcare providers are compensated for these services.
  • Coverage Requirements: It mandates that health insurance plans cover the costs associated with rapid WGS, thereby reducing the financial burden on patients and their families.
  • Implementation Timeline: The bill includes provisions for the implementation of these payment structures, although specific timelines are not detailed in the summary.

Affected Parties

  • Patients: Individuals requiring rapid whole genome sequencing for diagnostic purposes will benefit from improved access and reduced out-of-pocket costs.
  • Healthcare Providers: Hospitals and laboratories offering genomic sequencing services will receive clear guidelines on reimbursement, facilitating their ability to provide these advanced tests.
  • Insurance Companies: Health insurers will need to adjust their policies to comply with the new coverage requirements established by the bill.

Legislative Actions

  • January 30, 2025: The bill was introduced and referred to the Health Committee.
  • May 20, 2025: The bill was reported out of committee and committed to the Finance Committee for further consideration.

Related Legislation

  • S 7929: A related bill from the prior session that may address similar issues concerning genomic testing and payment.
  • A 1977: A companion bill in the Assembly that aligns with the objectives of S 3805, potentially facilitating a more comprehensive legislative approach to genomic testing reimbursement.

Conclusion

Bill S 3805 represents a significant step towards enhancing access to rapid whole genome sequencing, which is crucial for timely and accurate medical diagnoses. By establishing clear payment guidelines, the bill aims to support patients and healthcare providers alike, fostering advancements in genomic medicine. As the bill progresses through the legislative process, its implications for healthcare access and insurance coverage will be closely monitored.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.